Biocartis Group NV (EBR: BCART)
Belgium
· Delayed Price · Currency is EUR
0.290
0.00 (0.00%)
Jan 20, 2025, 9:00 AM CET
Biocartis Group NV Revenue
Biocartis Group NV had revenue of 29.62M EUR in the half year ending June 30, 2023, with 28.45% growth. This brings the company's revenue in the last twelve months to 60.82M, up 3.77% year-over-year. In the year 2022, Biocartis Group NV had annual revenue of 57.98M with 5.61% growth.
Revenue (ttm)
60.82M
Revenue Growth
+3.77%
P/S Ratio
0.37
Revenue / Employee
115.63K
Employees
526
Market Cap
27.24M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 57.98M | 3.08M | 5.61% |
Dec 31, 2021 | 54.90M | -661.00K | -1.19% |
Dec 31, 2020 | 55.56M | 17.83M | 47.25% |
Dec 31, 2019 | 37.73M | 9.08M | 31.70% |
Dec 31, 2018 | 28.65M | 5.54M | 23.98% |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
argenx SE | 1.71B |
UCB SA | 5.45B |
Fagron NV | 820.76M |
Nyxoah | 5.08M |
Ion Beam Applications | 465.75M |
Onward Medical | -188.00K |
Hyloris Pharmaceuticals | 6.94M |
Sequana Medical NV | 433.50K |